caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1710204573

Aref AgheliMD

Hematology-OncologyEast Syracuse, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Aref Agheli's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 17 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CORNING HOSPITAL133328
Hengbing Wang
Hematology-Oncology · Ukiah, CA
63476
Sandra Brewer
Nurse Practitioner · Sayre, PA
4375
NPI 108376078940173
Justin Seningen
Pathology · Robbinsdale, MN
2674
Mark Pilot
Diagnostic Radiology · Robbinsdale, MN
2276
Andrew Ruppert
Diagnostic Radiology · Robbinsdale, MN
2167
MAPLE GROVE HOSPITAL CORPORATION20112
Nellie Bauer
Diagnostic Radiology · Robbinsdale, MN
1971
Katharine Van Patten
Pathology · Robbinsdale, MN
1867
Eric Kehrberg
Pathology · Minneapolis, MN
1837
Laura Schmitz
Pathology · Minneapolis, MN
1658
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
9,104
Unique beneficiaries
—
Total services
94,375
Distinct HCPCS
89
Medicare payment
$739K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — top quintile (cohort median 883).
PRESCRIBING · PART D · 2024
Total Rx claims
148
Beneficiaries
—
Total drug cost
$131K
Distinct drugs
8
Brand share
60.8%
Top prescribed drugs
Ondansetron28 claims
Apixaban24 claims
Darbepoetin Alfa In Polysorbat20 claims
Prochlorperazine Maleate19 claims
Fosnetupitant/Palonosetron18 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
15.8
Cost
75.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$101
Payment records
2
By payment type
Food and Beverage$101